Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Vasant (Vas) Narasimhan
Klaus Moosmayer
Steffen Lang
Aharon Gal
Fiona H. Marshall
Harry Kirsch
Karen Hale
Kees Roks
Lutz Hegemann
Michelle Weese
Patrick Horber
Rob Kowalski
Shreeram Aradhye
Victor Bulto
Board:
Charles Sawyers
Nancy Andrews
Simon Moroney
Ana de Pro Gonzalo
Bridgette Heller
Daniel Hochstrasser
Frans van Houten
John Young
Mary Doherty
Patrice Bula
Ton Büchner
William Winters
Hans Jörg Reinhardt
Shareholding in %:
BlackRock Advisors (UK) Ltd. 0.81
BlackRock Fund Advisors 1.75
Credit Suisse Asset Management (Schweiz) AG 1.44
Norges Bank Investment Management 2.53
Novartis AG 6.63
Sandoz Family Foundation 4.07
The Vanguard Group, Inc. 3.56
UBS Asset Management Switzerland AG 3.12
Wellington Management Co. LLP 1.6
Zürcher Kantonalbank (Investment Management) 1.21
Freefloat 73.28
Address: Lichtstrasse 35, 4056 Basel
T: +41-61-324-11-11
F: +
I: http://www.novartis.com
E: